UniProt ID | GLD2_HUMAN | |
---|---|---|
UniProt AC | Q6PIY7 | |
Protein Name | Poly(A) RNA polymerase GLD2 | |
Gene Name | PAPD4 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 484 | |
Subcellular Localization | Cytoplasm. Nucleus. | |
Protein Description | Cytoplasmic poly(A) RNA polymerase that adds successive AMP monomers to the 3'-end of specific RNAs, forming a poly(A) tail. In contrast to the canonical nuclear poly(A) RNA polymerase, it only adds poly(A) to selected cytoplasmic mRNAs. Does not play a role in replication-dependent histone mRNA degradation.. | |
Protein Sequence | MFPNSILGRPPFTPNHQQHNNFFTLSPTVYSHQQLIDAQFNFQNADLSRAVSLQQLTYGNVSPIQTSASPLFRGRKRLSDEKNLPLDGKRQRFHSPHQEPTVVNQIVPLSGERRYSMPPLFHTHYVPDIVRCVPPFREIAFLEPREITLPEAKDKLSQQILELFETCQQQISDLKKKELCRTQLQREIQLLFPQSRLFLVGSSLNGFGTRSSDGDLCLVVKEEPCFFQVNQKTEARHILTLVHKHFCTRLSGYIERPQLIRAKVPIVKFRDKVSCVEFDLNVNNIVGIRNTFLLRTYAYLENRVRPLVLVIKKWASHHQINDASRGTLSSYSLVLMVLHYLQTLPEPILPSLQKIYPESFSPAIQLHLVHQAPCNVPPYLSKNESNLGDLLLGFLKYYATEFDWNSQMISVREAKAIPRPDGIEWRNKYICVEEPFDGTNTARAVHEKQKFDMIKDQFLKSWHRLKNKRDLNSILPVRAAVLKR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
52 | Phosphorylation | ADLSRAVSLQQLTYG CCHHHCCCHHHCCCC | 21.34 | 27174698 | |
57 | Phosphorylation | AVSLQQLTYGNVSPI CCCHHHCCCCCCCCC | 25.66 | 27174698 | |
58 | Phosphorylation | VSLQQLTYGNVSPIQ CCHHHCCCCCCCCCC | 18.46 | 20090780 | |
62 | Phosphorylation | QLTYGNVSPIQTSAS HCCCCCCCCCCCCCC | 21.93 | 21712546 | |
66 | Phosphorylation | GNVSPIQTSASPLFR CCCCCCCCCCCHHCC | 27.29 | 30108239 | |
67 | Phosphorylation | NVSPIQTSASPLFRG CCCCCCCCCCHHCCC | 15.46 | 22199227 | |
69 | Phosphorylation | SPIQTSASPLFRGRK CCCCCCCCHHCCCCC | 23.15 | 22199227 | |
73 | Methylation | TSASPLFRGRKRLSD CCCCHHCCCCCCCCC | 52.25 | 12019631 | |
75 | Methylation | ASPLFRGRKRLSDEK CCHHCCCCCCCCCCC | 19.37 | 30760605 | |
82 | Ubiquitination | RKRLSDEKNLPLDGK CCCCCCCCCCCCCCC | 69.63 | - | |
89 | Ubiquitination | KNLPLDGKRQRFHSP CCCCCCCCCCCCCCC | 45.05 | - | |
90 | Methylation | NLPLDGKRQRFHSPH CCCCCCCCCCCCCCC | 38.14 | 115486401 | |
92 | Methylation | PLDGKRQRFHSPHQE CCCCCCCCCCCCCCC | 34.97 | 115486407 | |
95 | Phosphorylation | GKRQRFHSPHQEPTV CCCCCCCCCCCCCCE | 22.74 | 23401153 | |
101 | Phosphorylation | HSPHQEPTVVNQIVP CCCCCCCCEEEEEEE | 36.01 | 30576142 | |
110 | Phosphorylation | VNQIVPLSGERRYSM EEEEEECCCCCCCCC | 32.32 | 21712546 | |
115 | Phosphorylation | PLSGERRYSMPPLFH ECCCCCCCCCCCCCC | 18.62 | 30108239 | |
116 | Phosphorylation | LSGERRYSMPPLFHT CCCCCCCCCCCCCCC | 24.01 | 30108239 | |
123 | Phosphorylation | SMPPLFHTHYVPDIV CCCCCCCCCCCCCHH | 13.94 | 28387310 | |
125 | Phosphorylation | PPLFHTHYVPDIVRC CCCCCCCCCCCHHHC | 18.16 | 28387310 | |
131 | Methylation | HYVPDIVRCVPPFRE CCCCCHHHCCCCCHH | 18.95 | 54557899 | |
153 | Ubiquitination | EITLPEAKDKLSQQI EECCHHHHHHHHHHH | 54.45 | - | |
155 | Ubiquitination | TLPEAKDKLSQQILE CCHHHHHHHHHHHHH | 49.70 | - | |
175 | Ubiquitination | QQQISDLKKKELCRT HHHHHHHHHHHHHHH | 67.78 | - | |
211 | Phosphorylation | LNGFGTRSSDGDLCL CCCCCCCCCCCCEEE | 32.39 | 29083192 | |
212 | Phosphorylation | NGFGTRSSDGDLCLV CCCCCCCCCCCEEEE | 42.18 | 29083192 | |
251 | Phosphorylation | KHFCTRLSGYIERPQ HHHHHHHHCCCCCCH | 26.68 | 27251275 | |
253 | Phosphorylation | FCTRLSGYIERPQLI HHHHHHCCCCCCHHH | 9.02 | - | |
268 | Ubiquitination | RAKVPIVKFRDKVSC HCCCCEEECCCCEEE | 35.09 | - | |
325 | Methylation | HQINDASRGTLSSYS CCCCCCCCCCCHHHH | 43.78 | 30762835 | |
325 | Dimethylation | HQINDASRGTLSSYS CCCCCCCCCCCHHHH | 43.78 | - | |
428 | Ubiquitination | DGIEWRNKYICVEEP CCCCEECCEEEEECC | 27.67 | - | |
429 | Phosphorylation | GIEWRNKYICVEEPF CCCEECCEEEEECCC | 11.78 | - | |
439 | Phosphorylation | VEEPFDGTNTARAVH EECCCCCCHHHHHHH | 31.10 | - | |
441 | Phosphorylation | EPFDGTNTARAVHEK CCCCCCHHHHHHHHH | 19.84 | - | |
455 | Ubiquitination | KQKFDMIKDQFLKSW HHHHHHHHHHHHHHH | 38.55 | - | |
461 | Phosphorylation | IKDQFLKSWHRLKNK HHHHHHHHHHHHCCC | 30.20 | 20068231 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of GLD2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of GLD2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of GLD2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-69, AND MASSSPECTROMETRY. |